Cigna Corporation (NYSE: CI) Stock Competitors & Peer Comparison
See CI's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CI and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CI | $273.87 | -1.63% | 72.4B | 8.86 | $30.90 | +2.26% |
| UNH | $402.19 | -1.60% | 365.3B | 24.61 | $16.34 | +2.22% |
| CVS | $93.50 | -2.27% | 119.3B | 11.93 | $7.84 | +2.85% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| ELV | $390.37 | -1.84% | 84.7B | 13.28 | $29.39 | +1.76% |
| HUM | $372.82 | -3.34% | 44.8B | 23.52 | $15.86 | +0.94% |
| CNC | $64.88 | -2.54% | 32B | 25.74 | $2.52 | N/A |
| MOH | $194.54 | -2.16% | 10.2B | 28.10 | $6.92 | N/A |
| OSCR | $27.97 | +1.08% | 7.2B | 19.97 | $1.40 | N/A |
| ALHC | $13.20 | -4.21% | 2.7B | 146.67 | $0.09 | N/A |
Stock Comparison
UnitedHealth Group Incorporated (NYSE: UNH)
CI vs UNH Comparison August 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 72.4B. In comparison, UNH has a market cap of 365.3B. Regarding current trading prices, CI is priced at $273.87 on the NYSE, while UNH trades at $402.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 8.86, whereas UNH's P/E ratio is 24.61. In terms of profitability, CI's ROE is +0.15%, compared to UNH's ROE of +0.14%. Regarding short-term risk, CI is more volatile compared to UNH. This indicates higher risk in terms of short-term price fluctuations for CI.Check UNH's competition here
CVS Health Corp. (NYSE: CVS)
CI vs CVS Comparison August 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 72.4B. In comparison, CVS has a market cap of 119.3B. Regarding current trading prices, CI is priced at $273.87 on the NYSE, while CVS trades at $93.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 8.86, whereas CVS's P/E ratio is 11.93. In terms of profitability, CI's ROE is +0.15%, compared to CVS's ROE of +0.06%. Regarding short-term risk, CI is less volatile compared to CVS. This indicates lower risk in terms of short-term price fluctuations for CI.Check CVS's competition here
Elevance Health Inc. (NYSE: ANTM)
CI vs ANTM Comparison August 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 72.4B. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, CI is priced at $273.87 on the NYSE, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 8.86, whereas ANTM's P/E ratio is 18.99. In terms of profitability, CI's ROE is +0.15%, compared to ANTM's ROE of +0.11%. Regarding short-term risk, CI is less volatile compared to ANTM. This indicates lower risk in terms of short-term price fluctuations for CI.Check ANTM's competition here
Elevance Health Inc. (NYSE: ELV)
CI vs ELV Comparison August 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 72.4B. In comparison, ELV has a market cap of 84.7B. Regarding current trading prices, CI is priced at $273.87 on the NYSE, while ELV trades at $390.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 8.86, whereas ELV's P/E ratio is 13.28. In terms of profitability, CI's ROE is +0.15%, compared to ELV's ROE of +0.11%. Regarding short-term risk, CI is less volatile compared to ELV. This indicates lower risk in terms of short-term price fluctuations for CI.Check ELV's competition here
Humana Inc. (NYSE: HUM)
CI vs HUM Comparison August 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 72.4B. In comparison, HUM has a market cap of 44.8B. Regarding current trading prices, CI is priced at $273.87 on the NYSE, while HUM trades at $372.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 8.86, whereas HUM's P/E ratio is 23.52. In terms of profitability, CI's ROE is +0.15%, compared to HUM's ROE of +0.07%. Regarding short-term risk, CI is less volatile compared to HUM. This indicates lower risk in terms of short-term price fluctuations for CI.Check HUM's competition here
Centene Corp. (NYSE: CNC)
CI vs CNC Comparison August 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 72.4B. In comparison, CNC has a market cap of 32B. Regarding current trading prices, CI is priced at $273.87 on the NYSE, while CNC trades at $64.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 8.86, whereas CNC's P/E ratio is 25.74. In terms of profitability, CI's ROE is +0.15%, compared to CNC's ROE of -0.24%. Regarding short-term risk, CI is less volatile compared to CNC. This indicates lower risk in terms of short-term price fluctuations for CI.Check CNC's competition here
Molina Healthcare, Inc. (NYSE: MOH)
CI vs MOH Comparison August 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 72.4B. In comparison, MOH has a market cap of 10.2B. Regarding current trading prices, CI is priced at $273.87 on the NYSE, while MOH trades at $194.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 8.86, whereas MOH's P/E ratio is 28.10. In terms of profitability, CI's ROE is +0.15%, compared to MOH's ROE of -0.00%. Regarding short-term risk, CI is less volatile compared to MOH. This indicates lower risk in terms of short-term price fluctuations for CI.Check MOH's competition here
Oscar Health, Inc. (NYSE: OSCR)
CI vs OSCR Comparison August 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 72.4B. In comparison, OSCR has a market cap of 7.2B. Regarding current trading prices, CI is priced at $273.87 on the NYSE, while OSCR trades at $27.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 8.86, whereas OSCR's P/E ratio is 19.97. In terms of profitability, CI's ROE is +0.15%, compared to OSCR's ROE of +0.39%. Regarding short-term risk, CI is less volatile compared to OSCR. This indicates lower risk in terms of short-term price fluctuations for CI.Check OSCR's competition here
Alignment Healthcare, Inc. (NASDAQ: ALHC)
CI vs ALHC Comparison August 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 72.4B. In comparison, ALHC has a market cap of 2.7B. Regarding current trading prices, CI is priced at $273.87 on the NYSE, while ALHC trades at $13.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 8.86, whereas ALHC's P/E ratio is 146.67. In terms of profitability, CI's ROE is +0.15%, compared to ALHC's ROE of +0.20%. Regarding short-term risk, CI is less volatile compared to ALHC. This indicates lower risk in terms of short-term price fluctuations for CI.Check ALHC's competition here
Clover Health Investments, Corp. (NASDAQ: CLOV)
CI vs CLOV Comparison August 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 72.4B. In comparison, CLOV has a market cap of 2.3B. Regarding current trading prices, CI is priced at $273.87 on the NYSE, while CLOV trades at $4.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 8.86, whereas CLOV's P/E ratio is 102.95. In terms of profitability, CI's ROE is +0.15%, compared to CLOV's ROE of -0.05%. Regarding short-term risk, CI is less volatile compared to CLOV. This indicates lower risk in terms of short-term price fluctuations for CI.Check CLOV's competition here
Bright Health Group, Inc. (NYSE: BHG)
CI vs BHG Comparison August 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 72.4B. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, CI is priced at $273.87 on the NYSE, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 8.86, whereas BHG's P/E ratio is -0.12. In terms of profitability, CI's ROE is +0.15%, compared to BHG's ROE of +0.04%. Regarding short-term risk, CI is less volatile compared to BHG. This indicates lower risk in terms of short-term price fluctuations for CI.Check BHG's competition here
Caring Brands, Inc. (NASDAQ: CABR)
CI vs CABR Comparison August 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 72.4B. In comparison, CABR has a market cap of 12.9M. Regarding current trading prices, CI is priced at $273.87 on the NYSE, while CABR trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 8.86, whereas CABR's P/E ratio is -2.54. In terms of profitability, CI's ROE is +0.15%, compared to CABR's ROE of -3.28%. Regarding short-term risk, CI is less volatile compared to CABR. This indicates lower risk in terms of short-term price fluctuations for CI.Check CABR's competition here
Triple-S Management Corporation (NYSE: GTS)
CI vs GTS Comparison August 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 72.4B. In comparison, GTS has a market cap of 0. Regarding current trading prices, CI is priced at $273.87 on the NYSE, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 8.86, whereas GTS's P/E ratio is 10.41. In terms of profitability, CI's ROE is +0.15%, compared to GTS's ROE of +0.07%. Regarding short-term risk, CI is more volatile compared to GTS. This indicates higher risk in terms of short-term price fluctuations for CI.Check GTS's competition here
Magellan Health, Inc. (NASDAQ: MGLN)
CI vs MGLN Comparison August 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 72.4B. In comparison, MGLN has a market cap of 0. Regarding current trading prices, CI is priced at $273.87 on the NYSE, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 8.86, whereas MGLN's P/E ratio is 8.49. In terms of profitability, CI's ROE is +0.15%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, CI is more volatile compared to MGLN. This indicates higher risk in terms of short-term price fluctuations for CI.Check MGLN's competition here
Aetna Inc. (NYSE: AET)
CI vs AET Comparison August 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 72.4B. In comparison, AET has a market cap of 0. Regarding current trading prices, CI is priced at $273.87 on the NYSE, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 8.86, whereas AET's P/E ratio is 9.57. In terms of profitability, CI's ROE is +0.15%, compared to AET's ROE of +0.11%. Regarding short-term risk, CI is more volatile compared to AET. This indicates higher risk in terms of short-term price fluctuations for CI.Check AET's competition here
Universal American Corporation (NYSE: UAM)
CI vs UAM Comparison August 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 72.4B. In comparison, UAM has a market cap of 0. Regarding current trading prices, CI is priced at $273.87 on the NYSE, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 8.86, whereas UAM's P/E ratio is 1.01. In terms of profitability, CI's ROE is +0.15%, compared to UAM's ROE of +0.17%. Regarding short-term risk, CI is more volatile compared to UAM. This indicates higher risk in terms of short-term price fluctuations for CI.Check UAM's competition here